Irbesartan Dosing for Hypertension
For hypertension, start irbesartan at 150 mg once daily, and titrate to a maximum of 300 mg once daily as needed for blood pressure control. 1
Standard Dosing Regimen
Initial Dose
- 150 mg once daily is the recommended starting dose for most patients with hypertension 1
- Can be taken with or without food 1
- Antihypertensive effect is apparent after the first dose, with near-maximal effect achieved within 2 weeks 1
Titration and Maximum Dose
- Increase to 300 mg once daily if blood pressure is not adequately controlled 1
- 300 mg once daily is the maximum effective dose - no additional benefit is seen at higher doses 1
- The 300 mg dose provides blood pressure reductions of approximately 8-12/5-8 mmHg compared to placebo 1
Timing Considerations
- Once-daily dosing provides 24-hour blood pressure control with trough-to-peak ratios of 60-70% 1
- Peak effects occur at 3-6 hours post-dose 1
- Take at the most convenient time of day to establish a habitual pattern and improve adherence 2
Special Populations
Volume or Salt Depletion
Start with 75 mg once daily in patients with:
- Intravascular volume depletion
- Salt depletion (e.g., vigorous diuretic therapy)
- Hemodialysis patients 1
Renal Impairment
No dose adjustment necessary for any degree of renal impairment, including patients on hemodialysis 1, 3
- Pharmacokinetic studies show no significant relationship between creatinine clearance and drug exposure 3
- Irbesartan is not cleared by hemodialysis 3
Hepatic Impairment
No dose adjustment necessary in patients with hepatic disease 1
Elderly Patients
No dose adjustment required - elderly patients show similar responses to younger patients 1
Combination Therapy Context
Current hypertension guidelines emphasize that most patients require combination therapy 4, 2:
- For stage 2 hypertension (≥140/90 mmHg), initial combination therapy is recommended rather than monotherapy 2
- Irbesartan combines effectively with:
- Single-pill combinations are preferred when combination therapy is needed to improve adherence 2
Diabetic Nephropathy
For patients with type 2 diabetes and nephropathy, the recommended dose is 300 mg once daily 1 - this is the dose proven to reduce progression to end-stage renal disease 1
Critical Safety Considerations
Never combine irbesartan with other RAS blockers (ACE inhibitors or other ARBs) - this combination is not recommended due to potential for harm 4, 2
Common Pitfall
Do not exceed 300 mg daily thinking higher doses will provide additional benefit - clinical trials demonstrate no further blood pressure reduction beyond 300 mg 1. This wastes resources and may increase side effects without improving outcomes.